CAMBRIDGE, Mass., Nov. 12,
2024 /PRNewswire/ -- Akebia Therapeutics®,
Inc. (Nasdaq: AKBA), a biopharmaceutical company with the
purpose to better the lives of people impacted by kidney disease,
today announced that John Butler,
Chief Executive Officer, will present at the Jefferies London
Healthcare Conference on Thursday, November
21 at 1:00 PM GMT.
A webcast of the presentation can be accessed through the
"Investors" section of Akebia's website at
https://ir.akebia.com for 30 days following the
conference.
The Jefferies London Healthcare Conference will take place
November 19-21, 2024 in London.
About Akebia Therapeutics
Akebia Therapeutics, Inc. is
a fully integrated biopharmaceutical company with the purpose to
better the lives of people impacted by kidney disease. Akebia was
founded in 2007 and is headquartered in Cambridge, Massachusetts. For more
information, please visit our website at www.akebia.com, which does
not form a part of this release.
Akebia Therapeutics Contact
Mercedes Carrasco
mcarrasco@akebia.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-to-present-at-the-jefferies-london-healthcare-conference-302301773.html
SOURCE Akebia Therapeutics, Inc.
